Last updated: 2026-09-05 19:46:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CVRx, Inc. (CVRX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $3,05, with a market capitalization of $81,79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,20 to $11,30. This page covers its latest market performance, valuation, price trends and company information.
$81,79M | |
$2,99 | |
$33,14 | |
$2,20 | |
$3,01 | |
817,43K | |
-- | |
-- | |
$11,30 | |
$2,20 | |
-- | |
-- |
CVRx, Inc. (CVRX) last closed at $3,01 as of 2026-09-04 23:31:00, unchanged from the previous close of $3,01.
During the latest regular trading session, CVRX traded between $2,20 and $33,14, with a volume of 817,43K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, CVRx, Inc. (CVRX) moved from $2,97 to $3,05, representing a gain of 2,53% ($0,07).
The stock traded between $2,97 and $3,13 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 637,89 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 9,3%
CVRX is currently trading at $3,05, placing it 9,3% of the way from its 52-week low of $2,20 to its 52-week high of $11,30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 223 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CVRx, Inc. (CVRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.